Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Leukemia
Sort By
Newest First
Sign in
1 / 1
1 / 1
Research
Overlooked Molecular Machine in Cell Nucleus May Hold Key to Treating Aggressive Leukemia
PA2702
Apr 23, 2019
Leukemia
Astellas Presents Updated Results from Phase 1 Study of Gilteritinib Plus Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
Astellas
PR-M12-18-NI-025
Dec 07, 2018
Collaboration
Tolero Pharmaceuticals Announces Clinical Research Collaboration with AbbVie for Acute Myeloid Leukemia Trial
Tolero Pharmaceuticals
PR-M09-18-NI-071
Sep 24, 2018
Clinical Trial
Trovagene Announces Completion of Second Dosing Cohort of Patients Treated with Onvansertib (PCM-075) in Ongoing Phase 1b/2 AML Trial
Trovagene
PR-M09-18-NI-061
Sep 20, 2018
Collaboration
Amgen And MD Anderson Announce Collaboration To Accelerate Early Stage Treatments For Cancer
Amgen
PR-M06-18-NI-028
Jun 08, 2018
Innovation
Celgene’s First-Ever Oral Leukemia Treatment Gets FDA Nod
Nigel Walker
Nice Insight
PAO-M08-17-NI-012
Aug 08, 2017
